Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | PAM | P19021 | 2/20 | 0.52 |
| ▸ | CES2 | O00748 | 3/20 | 0.50 |
| ▸ | CES1 | P23141 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 5/20 | 0.48 |
| ▸ | PPARG | P37231 | 6/20 | 0.48 |
| ▸ | PPARD | Q03181 | 6/20 | 0.48 |
| ▸ | PPARA | Q07869 | 6/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3658855 | 1.00 | DGKA (0.57) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL3823631 | 1.00 | DGKA (0.57) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL2918263 | 1.00 | DGKA (0.57) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL9768598 | 1.00 | DGKA (0.57) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL5732818 | 1.00 | DGKA (0.57) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL7771101 | 1.00 | DGKA (0.57) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL3121472 | 1.00 | DGKA (0.57) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL9985650 | 1.00 | DGKA (0.57) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL62214 | 1.00 | DGKA (0.57) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL1510009 | 1.00 | DGKA (0.57) | DGKALMNAPAMCES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113754753-B | Synthetic method of somalupeptide | 深圳翰宇药业股份有限公司 | 2024-09-03 | — | — | CN | disclosed |
| CN-101932601-B | Insulin derivates | 诺沃-诺迪斯克有限公司 | 2016-08-03 | — | — | CN | disclosed |
| CN-101784562-B | There is the insulin analog of acyl group and aklylene glycol moiety | 诺沃-诺迪斯克有限公司 | 2016-07-13 | — | — | CN | disclosed |
| CN-101133082-B | ACYLATED GLP-1 COMPOUNDS | NOVO NORDISK A/S (DK) | 2016-01-13 | — | — | CN | disclosed |
| CN-105154498-A | Semi-recombinant preparation of GLP-1 analogues | NOVO NORDISK AS | 2015-12-16 | — | — | CN | disclosed |
| EP-2217621-B1 | INSULIN DERIVATIVE | NOVO NORDISK AS (DK) | 2015-04-22 | — | — | EP | disclosed |
| CN-104402989-A | ACYLATED GLP-1 COMPOUNDS | NOVO NORDISK AS | 2015-03-11 | — | — | CN | disclosed |
| CN-101784563-B | Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids | NOVO NORDISK AS | 2015-02-04 | — | — | CN | disclosed |
| CN-104185639-A | GLP-1 prodrugs | NOVO NORDISK AS | 2014-12-03 | — | — | CN | disclosed |
| CN-104017062-A | Acylated GLP-1 compounds | NOVO NORDISK AS | 2014-09-03 | — | — | CN | disclosed |
| CN-102333788-A | Modification of factor viii | NOVO NORDISK AS | 2012-01-25 | — | — | CN | disclosed |
| CN-101932601-A | Insulin derivative | NOVO NORDISK AS | 2010-12-29 | — | — | CN | disclosed |
| CN-101910193-A | Semi-recombinant preparation method of GLP-1 analogue | NOVO NORDISK AS | 2010-12-08 | — | — | CN | disclosed |
| EP-2217621-A1 | INSULIN DERIVATIVE | Novo Nordisk A/S (DK) | 2010-08-18 | — | — | EP | disclosed |
| CN-101784563-A | insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids | NOVO NORDISK AS | 2010-07-21 | — | — | CN | disclosed |
| WO-2009060071-A1 | INSULIN DERIVATIVE | NOVO NORDISK A/S (DK) | 2009-05-14 | — | — | WO | disclosed |
| EP-2058330-A1 | Insulin derivative | NOVO NORDISK A/S (DK) | 2009-05-13 | — | — | EP | disclosed |
| CN-101133082-A | Acylated GLP-1 compounds | NOVO NORDISK AS (DK) | 2008-02-27 | — | — | CN | disclosed |